EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of HIV-infected subjects with granulocytic CSF



Treatment of HIV-infected subjects with granulocytic CSF



Immunologiya (6): 10-12, November-December




(PDF 0-2 workdays service: $29.90)

Accession: 035980463

Download citation: RISBibTeXText



Related references

Exploratory clinical studies of a synthetic HIV-1 Tat epitope vaccine in asymptomatic treatment-naïve and antiretroviral-controlled HIV-1 infected subjects plus healthy uninfected subjects. Human Vaccines & Immunotherapeutics 8(4): 479-485, 2013

Absorption and excretion of vitamin B12 in subjects infected with Diphyllobothrium latum and in non-infected subjects following oral administration of radioactive B12. Acta Haematologica 19(2): 90-98, 1958

Quantitative evaluation of ehrlichial burden in horses after experimental transmission of human granulocytic Ehrlichia agent by intravenous inoculation with infected leukocytes and by infected ticks. Journal of Clinical Microbiology 37(12): 4042-4044, 1999

Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial. Plos One 11(5): E0154842-E0154842, 2016

Barriers to ART initiation in HIV infected subjects and with treatment indication in Spain. Why don't they start their treatment? Bridgap Study. Enfermedades Infecciosas Y Microbiologia Clinica 33(6): 397-403, 2015

Influence of prior structured treatment interruptions on the length of time without antiretroviral treatment in chronically HIV-infected subjects. Aids Research and Human Retroviruses 20(12): 1283-1288, 2005

Treatment interruptions in HIV-infected subjects. Journal of Antimicrobial ChemoTherapy 58(3): 502-505, 2006

Zidovudine treatment of asymptomatic hiv infected subjects. Journal of Cellular Biochemistry Supplement (13 PART B): 302, 1989

Lactacidaemia in asymptomatic HIV-infected subjects under NRTI treatment. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 313, 2001

Virological evaluation of zidovudine azt treatment in hiv infected subjects. Bollettino Societa Italiana Biologia Sperimentale 66(6): 601-606, 1990

Notes on the use of fluvoxamine as treatment of depression in HIV-1-infected subjects. Pharmacopsychiatry 28(3): 93-94, 1995

Treatment of syphilis in HIV-infected subjects: a systematic review of the literature. Sexually Transmitted Infections 87(1): 9-16, 2011

Process of determining the efficacy of drug treatment in HIV infected subjects. Official Gazette of the United States Patent & Trademark Office Patents 1245(1), Apr 3, 2001

Effect of antifungal treatment on the prevalence of yeasts in HIV-infected subjects. Journal of Medical Microbiology 55(Pt 9): 1279-1284, 2006

Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects. Antiviral Research 13(3): 127-138, 1990